Joseph L. Pater

23.5k total citations · 7 hit papers
147 papers, 16.3k citations indexed

About

Joseph L. Pater is a scholar working on Oncology, Economics and Econometrics and Surgery. According to data from OpenAlex, Joseph L. Pater has authored 147 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 37 papers in Economics and Econometrics and 28 papers in Surgery. Recurrent topics in Joseph L. Pater's work include Health Systems, Economic Evaluations, Quality of Life (35 papers), Statistical Methods in Clinical Trials (17 papers) and Estrogen and related hormone effects (17 papers). Joseph L. Pater is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (35 papers), Statistical Methods in Clinical Trials (17 papers) and Estrogen and related hormone effects (17 papers). Joseph L. Pater collaborates with scholars based in Canada, United States and United Kingdom. Joseph L. Pater's co-authors include Benny Zee, David Osoba, James D. Myles, George Rodrigues, Lesley Seymour, Dongsheng Tu, Michael Palmer, David Warr, Kathleen I. Pritchard and Jean Latreille and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Joseph L. Pater

144 papers receiving 15.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interpreting the significance of changes in health-related quality-of-life scores.

1998 2.3k citations David Osoba, George Rodrigues et al. Journal of Clinical Oncology profile →
Quality of life and pharmacoeconomics in clinical trials

1996 2.0k citations Joseph L. Pater Controlled Clinical Trials profile →
Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

2005 1.5k citations Keyue Ding, Joseph L. Pater et al. profile →
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

2002 1.1k citations Brian O’Sullivan, Aileen M. Davis et al. The Lancet profile →
Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

2005 818 citations Silvana Martino, Nicholas J. Robert et al. profile →
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 544 citations Joseph L. Pater, Andrew R. Willan et al. Journal of Clinical Oncology profile →
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1993 515 citations Nevin Murray, Joseph L. Pater et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph L. Pater Canada	51	8.1k	6.2k	3.1k	2.0k	1.7k	147	16.3k
Benjamin F. Hankey United States	39	9.5k 1.2×	5.3k 0.9×	2.9k 0.9×	2.1k 1.1×	1.2k 0.7×	76	18.0k
Matti Aapro Switzerland	80	10.6k 1.3×	4.0k 0.7×	6.5k 2.1×	2.1k 1.1×	1.6k 0.9×	492	22.4k
Ann S. Hamilton United States	63	5.0k 0.6×	4.3k 0.7×	2.4k 0.8×	1.8k 0.9×	1.7k 1.0×	316	13.9k
Nadia Howlader United States	28	8.5k 1.0×	4.5k 0.7×	2.1k 0.7×	3.2k 1.6×	1.8k 1.0×	52	17.4k
Phyllis A. Wingo United States	52	9.4k 1.2×	4.9k 0.8×	3.0k 1.0×	2.7k 1.3×	2.3k 1.3×	105	20.8k
Mark N. Levine Canada	84	6.7k 0.8×	3.8k 0.6×	6.7k 2.1×	4.3k 2.2×	966 0.6×	320	31.4k
Joan L. Warren United States	59	7.8k 1.0×	4.7k 0.8×	3.2k 1.0×	1.5k 0.8×	614 0.4×	147	16.4k
Michel P. Coleman United Kingdom	61	6.7k 0.8×	2.2k 0.4×	2.0k 0.6×	1.2k 0.6×	798 0.5×	291	13.3k
Arnold L. Potosky United States	70	7.3k 0.9×	6.9k 1.1×	2.8k 0.9×	1.1k 0.6×	581 0.3×	175	17.2k
Gregory R. Pond Canada	65	5.7k 0.7×	5.6k 0.9×	3.3k 1.0×	1.9k 1.0×	582 0.3×	575	15.8k

Countries citing papers authored by Joseph L. Pater

Since Specialization

Citations

This map shows the geographic impact of Joseph L. Pater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Pater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Pater more than expected).

Fields of papers citing papers by Joseph L. Pater

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph L. Pater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Pater. The network helps show where Joseph L. Pater may publish in the future.

Co-authorship network of co-authors of Joseph L. Pater

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph L. Pater. A scholar is included among the top collaborators of Joseph L. Pater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph L. Pater. Joseph L. Pater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Osoba, David, George Rodrigues, James D. Myles, Benny Zee, & Joseph L. Pater. (2023). Interpreting the Significance of Changes in Health-Related Quality-of-Life Scores. Journal of Clinical Oncology. 41(35). 5345–5350. 16 indexed citations

Rodríguez‐Romo, Laura, Ralph M. Meyer, Joseph L. Pater, et al.. (2017). Comparison of Outcomes By Age of Patients with Limited Stage Hodgkin Lymphoma Treated with ABVD Alone; A Secondary Analysis of the Canadian Cancer Trial Group HD.6 Trial. Blood. 130. 4081–4081. 1 indexed citations

Cheung, Winson Y., Nicole Mittmann, Natasha B. Leighl, et al.. (2016). The economic impact of the transition from branded to generic oncology drugs.. Journal of Clinical Oncology. 34(15_suppl). 6520–6520.

Dudgeon, Deborah, Éduardo Bruera, Bruno Gagnon, et al.. (2007). A Phase III Randomized, Double-Blind, Placebo-Controlled Study Evaluating Dextromethorphan Plus Slow-Release Morphine for Chronic Cancer Pain Relief in Terminally Ill Patients. Journal of Pain and Symptom Management. 33(4). 365–371. 23 indexed citations

Osoba, David, Andrea Bezjak, Michael Brundage, & Joseph L. Pater. (2007). Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience. Value in Health. 10. S138–S145. 25 indexed citations

Goss, Paul E., J. N. Ingle, Silvana Martino, et al.. (2004). Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer. Journal of Clinical Oncology. 22(14_suppl). 847–847. 63 indexed citations

O’Sullivan, Brian, Aileen M. Davis, Robert Turcotte, et al.. (2004). Five-year results of a randomized phase III trial of pre-operative vs post-operative radiotherapy in extremity soft tissue sarcoma. Journal of Clinical Oncology. 22(14_suppl). 9007–9007. 59 indexed citations

Martin, Douglas K., Joseph L. Pater, & Peter Singer. (2001). Priority-setting decisions for new cancer drugs: a qualitative case study. The Lancet. 358(9294). 1676–1681. 95 indexed citations

Latreille, Jean, Joseph L. Pater, D. Johnston, et al.. (1998). Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 16(3). 1174–1178. 93 indexed citations

10.

Zee, Benny, Bernard F. Cole, George P. Browman, et al.. (1998). Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma.. Journal of Clinical Oncology. 16(8). 2834–2839. 26 indexed citations

11.

Pater, Joseph L., W. Lofters, Benny Zee, et al.. (1997). The role of the 5-HT3 antagonists ondansetron and dolasetron in the control of delayed onset nausea and vomiting in patients receiving moderately emetogenic chemotherapy. Annals of Oncology. 8(2). 181–185. 54 indexed citations

12.

Siu, L.L., Frances A. Shepherd, Nevin Murray, et al.. (1996). Influence of age in the treatment of limited-stage small-cell lung cancer. Pneumologie. 50(7). 1 indexed citations

13.

Pritchard, Kathleen I., et al.. (1996). Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.. Journal of Clinical Oncology. 14(10). 2731–2737. 205 indexed citations

14.

Osoba, David, Benny Zee, David Warr, et al.. (1996). Quality of Life Studies in Chemotherapy-Induced Emesis. Oncology. 53(1). 92–95. 66 indexed citations

15.

Warr, David, Peter Venner, Joseph L. Pater, et al.. (1993). A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. European Journal of Cancer. 29(1). 33–36. 29 indexed citations

16.

Zee, Benny & Joseph L. Pater. (1990). ·P-57 Sample size for trials where survival depends on first response rates. Controlled Clinical Trials. 11(4). 301–301. 1 indexed citations

17.

Willan, Andrew R. & Joseph L. Pater. (1986). Carryover and the two-period crossover clinical trial.. PubMed. 42(3). 593–9. 60 indexed citations

18.

Pater, Joseph L. & Andrew R. Willan. (1984). Methodologic issues in trials of antiemetics.. Journal of Clinical Oncology. 2(5). 484–487. 24 indexed citations

19.

Pater, Joseph L. & Mitchell Loeb. (1982). Nonanatomic prognostic factors in carcinoma of the lung. A multivariate analysis. Cancer. 50(2). 326–331. 76 indexed citations

20.

Pross, Hugh F., Joseph L. Pater, Isaac L. Dwosh, et al.. (1982). Studies of human natural killer cells. III. Neutropenia associated with unusual characteristics of antibody-dependent and natural killer cell-mediated cytotoxicity. Journal of Clinical Immunology. 2(2). 126–134. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact